Perspective Therapeutics, Inc. — Form SCHEDULE 13D/A
Filed September 4, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 28/100
What the filing says
Lantheus Holdings, Inc. filed an amended Schedule 13D/A regarding its beneficial ownership interest in Perspective Therapeutics, Inc. (market cap ~$212.9M). The filing date is September 4, 2026. The specific amendment details—including share count, percentage ownership, transaction amounts, and what changed from the prior filing—are not disclosed in the header/cover page provided; the actual amendment content would be in the referenced exhibits (EX-99.A and EX-99.10), which are not included in this text extract.
Why this rating
Schedule 13D/A amendments are routine regulatory filings. Without concrete details on ownership changes, transaction size, or strategic intent, this appears administrative. Material only if ownership crossed 5% or 10% thresholds or major stake change occurred—not evident here.
See more from September 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.